CNS TUMOR
Clinical trials for CNS TUMOR explained in plain language.
Never miss a new study
Get alerted when new CNS TUMOR trials appear
Sign up with your email to follow new studies for CNS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune drug PHST001 enters first human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug called PHST001, which helps the immune system attack cancer cells by blocking a protein called CD24. The study will first test PHST001 alone, then in combination with standard chemotherapy, in adults with advanced solid tumors (includi…
Matched conditions: CNS TUMOR
Phase: PHASE1 • Sponsor: Pheast Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for kids with deadly brain cancer? drug ONC206 enters human trials
Disease control Recruiting nowThis early-phase trial tests a new drug called ONC206 in children and young adults with diffuse midline glioma or other recurrent brain tumors. The drug aims to kill cancer cells by causing stress in them, without harming healthy cells. Researchers are looking for the safest dose…
Matched conditions: CNS TUMOR
Phase: PHASE1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for toddlers with rare brain tumors: targeted drug entrectinib tested
Disease control Recruiting nowThis study tests the drug entrectinib in children under 3 with certain brain tumors (NTRK or ROS1 gene fusions). The goal is to see if the drug can shrink tumors and delay the need for chemotherapy. About 52 children will take entrectinib by mouth, and doctors will monitor tumor …
Matched conditions: CNS TUMOR
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a smartphone app replace neurologist visits for brain tumor patients?
Knowledge-focused Recruiting nowThis study is testing whether a mobile app called 'Iskhaa' can help brain tumor patients perform their own neurological exams at home. Six hundred participants will use the app to record videos of tasks like speaking and walking, which an AI will analyze. The goal is to see if th…
Matched conditions: CNS TUMOR
Sponsor: Tata Memorial Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC